InvestorsHub Logo
Followers 42
Posts 12519
Boards Moderated 0
Alias Born 11/18/2016

Re: huskercatman123 post# 11354

Wednesday, 01/18/2017 9:11:16 PM

Wednesday, January 18, 2017 9:11:16 PM

Post# of 108192
Well ADXS vaccines are certainly biosimilar to each other. The indications are components of a platform technology. But I believe "biosimilar" in this FDA context refers to biosimilarity to previously approved molecules, and ADXS has none of those yet. Not sure what the upshot is, but Blue's hypothesis seems correct. Essentially expedited consideration/approval for additional ADXS indications under the same platform as an approved vaccine. If so, we still gotta break the ice first.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News